Expression profiles in pre-treatment biopsies from SCC of the head and neck correlate with outcome of radiotherapy.

被引：0
|
作者：
Akervall, Jan
Rontal, Eugene
Rontal, Michael
Alm, Jens
Gyllerup, Paulina
Gardinger, Ylva
Wennerberg, Johan
Scollon, Sarah
Haak, Pete
Brian, Haab
Dere, Ed
Furge, Kyle
Teh, Bin
机构：
[1] Beaumont Hosp, Farmington, MI USA
[2] Univ Hosp, Lund, Sweden
[3] Van Andel Inst, Grand Rapids, MI USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5184
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pre-treatment body mass composition affects survival in patients with head and neck cancer
    Talani, Charbel
    Astradsson, Thorsteinn
    Farnebo, Lovisa
    Makitie, Antti
    Laurell, Goran
    Ehrsson, Ylva Tiblom
    ORAL ONCOLOGY, 2021, 118
  • [22] Characterization of recurrence origin using pre-treatment PET/CT for head and neck cancers
    Beaumont, J.
    Acosta, O.
    Devillers, A.
    Palard-Novello, X.
    Chajon, E.
    De Crevoisier, R.
    Castelli, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S656 - S657
  • [23] Pre-treatment radiomic features predict individual nodal failure in head and neck cancer
    Zhai, T.
    Steenbakkers, R. J. H. M.
    Van Dijk, L. V.
    Vemer-van den Hoek, J. G. M.
    Bijl, H. P.
    Dieters, M.
    Noordzij, W.
    Van der Schaaf, A.
    Sijtsema, N. M.
    Langendijk, J. A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S204 - S204
  • [24] Pre-treatment Class Attendance and Outcomes in Head & Neck Cancer Patients Undergoing Radiation
    Malik, N.
    Maganti, M.
    McQuestion, M.
    Tjong, M. C.
    Keilty, D.
    Monteiro, E.
    Huang, S.
    Jang, R.
    Gomes, A.
    Pun, J.
    Ringash, J. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E378 - E378
  • [25] Pre-treatment FDG Standardized Uptake Value as a Prognostic Factor in Head and Neck Cancer
    Kavak, K.
    Aydin, M.
    Yapar, A.
    Reyhan, M.
    Nursal, G.
    Aktas, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S328 - S328
  • [26] Pre-treatment haemoglobin as a surrogate marker for survival in head & neck squamous cell carcinoma
    Tandon, S.
    Gairola, M.
    Ahlawat, P.
    Purohit, S.
    Umesh, P.
    Krishnan, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S805 - S806
  • [27] Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
    Brizel, DM
    Dodge, RK
    Clough, RW
    Dewhirst, MW
    RADIOTHERAPY AND ONCOLOGY, 1999, 53 (02) : 113 - 117
  • [28] The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
    Zhong, Haoyu
    Men, Kuo
    Wang, Jiazhou
    van Soest, Johan
    Rosenthal, David
    Dekker, Andre
    Zhang, Zhen
    Xiao, Ying
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [29] Role of immuno-therapy as a adjuvant treatment in advance head & neck cancer, patient receiving chemo radiotherapy.
    Pant, MC
    Hadi, R
    Prasad, R
    Dalela, D
    Pant, R
    Parmar, D
    Srivastava, M
    Parikh, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 190S - 190S
  • [30] Predicting Response toNeoadjuvant Therapy from Oesophageal Adenocarcinoma Pre-Treatment Biopsies
    Lloyd, M.
    Izadi, F.
    Rahman, S.
    Walker, R.
    Harrington, J.
    Hayden, A.
    Grace, B.
    Horne, J.
    Machado, M.
    Underwood, T.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 14 - 14
12345